Transforming growth factor-β1 polymorphisms and breast cancer risk: A meta-analysis based on 27 case-control studies

Breast Cancer Research and Treatment

Volumn 122, Issue 1, 2010, Pages 273-279

  Qi, Xiaowei ^a   Zhang, Fan ^a   Yang, Xinhua ^a   Fan, Linjun ^a   Zhang, Yi ^a   Chen, Li ^a   Zhou, Yan ^a   Chen, Xianchun ^a   Zhong, Ling ^a   Jiang, Jun ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Meta analysis; Polymorphism; Transforming growth factor 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CAUCASIAN; ETHNIC DIFFERENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; PENETRANCE; PRIORITY JOURNAL; AMINO ACID SUBSTITUTION; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MODEL; BREAST NEOPLASMS; COMPARATIVE STUDY; ETHNIC GROUP; ETHNOLOGY; EXON; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MENOPAUSE; META ANALYSIS; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICS AND NUMERICAL DATA;

AMINO ACID SUBSTITUTION; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CASE-CONTROL STUDIES; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MENOPAUSE; MODELS, GENETIC; ODDS RATIO; PENETRANCE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77953536277     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-0847-6     Document Type: Article

References (52)

1. R Derynck RJ Akhurst A Balmain 2001 TGF-beta signaling in tumor suppression and cancer progression Nat Genet 29 117 129 10.1038/ng1001-117 1:CAS:528:DC%2BD3MXnsFKgt7c%3D 11586292 (Pubitemid 32952643)
2. JR Benson 2004 Role of transforming growth factor β in breast carcinogenesis Lancet Oncol 5 229 239 10.1016/S1470-2045(04)01426-3 1:CAS:528:DC%2BD2cXisFOgtr0%3D 15050954 (Pubitemid 38391218)
3. B Bierie HL Moses 2006 Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer Nat Rev Cancer 6 506 520 10.1038/nrc1926 1:CAS:528:DC%2BD28XmtFegsr4%3D 16794634 (Pubitemid 43980540)
4. J Massagué 2008 TGFbeta in cancer Cell 134 215 230 10.1016/j.cell.2008.07.001 18662538 (Pubitemid 352010335)
5. JP Thiery H Acloque RY Huang MA Nieto 2009 Epithelial-mesenchymal transitions in development and disease Cell 139 871 890 10.1016/j.cell.2009.11. 007 1:CAS:528:DC%2BC3cXksFWltA%3D%3D 19945376
6. S Desruisseau J Palmari C Giusti S Romain P-M Martin Y Berthois 2006 Determination of TGFbeta1 protein level in human primary breast cancers and its relationship with survival Br J Cancer 94 239 246 10.1038/sj.bjc.6602920 1:CAS:528:DC%2BD28XmvVygtQ%3D%3D 16404434 (Pubitemid 43151542)
7. AM Grau W Wen D Ramroopsignh YT Gao J Zi Q Cai XO Shu W Zheng 2008 Circulating transforming growth factor-beta 1 and breast cancer prognosis: results from the Shanghai Breast Cancer Study Breast Cancer Res Treat 112 335 341 10.1007/s10549-007-9845-8 1:CAS:528:DC%2BD1cXht1Cms73O 18075785
8. W Zheng 2009 Genetic polymorphisms in the transforming growth factor-beta signaling pathways and breast cancer risk and survival Methods Mol Biol 472 265 277 10.1007/978-1-60327-492-0-11 1:CAS:528:DC%2BD1cXhsVeqt7fI 19107437
9. D Fujii JE Brissenden R Derynck U Francke 1986 Transforming growth factor beta gene maps to human chromosome 19 long arm and to mouse chromosome 7 Somat Cell Mol Genet 12 218 281 10.1007/BF01570787
10. SJ Chang CJ Chen FC Tsai HM Lai PC Tsai MH Tsai YC Ko 2008 Associations between gout tophus and polymorphisms 869T/C and -509C/T in transforming growth factor beta1 gene Rheumatology (Oxford) 47 617 621 10.1093/rheumatology/ken054 1:CAS:528:DC%2BD1cXkvFymsbY%3D (Pubitemid 351649183)
11. X Yuan Z Liao Z Liu LE Wang SL Tucker L Mao XS Wang M Martel R Komaki JD Cox L Milas Q Wei 2009 Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy J Clin Oncol 27 3370 3378 10.1200/JCO.2008.20.6763 1:CAS:528:DC%2BD1MXpvFejt7Y%3D 19380441
12. DJ Grainger K Heathcote M Chiano H Snieder PR Kemp JC Metcalfe ND Carter TD Spector 1999 Genetic control of the circulating concentration of transforming growth factor type beta1 Hum Mol Genet 8 93 97 10.1093/hmg/8.1.93 1:CAS:528:DyaK1MXoslChsw%3D%3D 9887336 (Pubitemid 29039053)
13. AM Dunning PD Ellis S McBride HL Kirschenlohr CS Healey PR Kemp RN Luben J Chang-Claude A Mannermaa V Kataja PD Pharoah DF Easton BA Ponder JC Metcalfe 2003 A transforming growth factor beta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer Cancer Res 63 2610 2615 1:CAS:528:DC%2BD3sXjsleht7w%3D 12750287
14. XO Shu YT Gao Q Cai L Pierce H Cai ZX Ruan G Yang F Jin W Zheng 2004 Genetic polymorphisms in the TGF-beta 1 gene and breast cancer survival: a report from the Shanghai breast cancer study Cancer Res 64 836 839 10.1158/0008-5472.CAN-03-3492 1:CAS:528:DC%2BD2cXhtFCgtLs%3D 14871809 (Pubitemid 38176881)
15. AM González-Zuloeta Ladd A Arias-Vásquez C Siemes JW Coebergh A Hofman J Witteman A Uitterlinden BH Stricker CM van Duijn 2007 Transforming-growth factor beta1 Leu10Pro polymorphism and breast cancer morbidity Eur J Cancer 43 371 374 10.1016/j.ejca.2006.08.021 17035001 (Pubitemid 46123980)
16. Wei BB, Xi B, Wang R, Bai JM, Chang JK, Zhang YY, Yoneda R, Su JT, Hua LX (2010) TGFbeta1 T29C polymorphism and cancer risk: a meta-analysis based on 40 case-control studies. Cancer Genet Cytogenet 196:68-75
17. A Cox AM Dunning M Garcia-Closas S Balasubramanian MW Reed KA Pooley S Scollen C Baynes BA Ponder S Chanock, et al. 2007 A common coding variant in CASP8 is associated with breast cancer risk Nat Genet 39 352 358 10.1038/ng1981 1:CAS:528:DC%2BD2sXitVOktrY%3D 17293864 (Pubitemid 46328496)
18. G Gonullu B Basturk T Evrensel B Oral A Gozkaman O Manavoglu 2007 Association of breast cancer and cytokine gene polymorphism in Turkish women Saudi Med J 28 1728 1733 17965799 (Pubitemid 350244364)
19. T Rajkumar M Samson R Rama V Sridevi U Mahji RK Swaminathan N Nancy 2008 TGFb1 (Leu10Pro), p53 (Arg72Pro) can predict for increased risk for breast cancer in south Indian women and TGFb1 Pro (Leu10Pro) allele predicts response to neo-adjuvant chemo-radiotherapy Breast Cancer Res Treat 112 81 87 10.1007/s10549-007-9821-3 1:CAS:528:DC%2BD1cXhtFOjtrnJ 18058229
20. DF Stroup JA Berlin SC Morton I Olkin GD Williamson D Rennie D Moher BJ Becker TA Sipe SB Thacker 2000 Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group JAMA 283 2008 2012 10.1001/jama.283.15.2008 1:STN:280:DC%2BD3c3kvVGgsA%3D%3D 10789670
21. J Little L Bradley MS Bray M Clyne J Dorman DL Ellsworth J Hanson M Khoury J Lau TR O'Brien N Rothman D Stroup E Taioli D Thomas H Vainio S Wacholder C Weinberg 2002 Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations Am J Epidemiol 156 300 310 12181099
22. Qi X, Ma X, Yang X, Fan L, Zhang Y, Zhang F, Chen L, Zhou Y, Jiang J (2010) Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls. Breast Cancer Res Treat. doi: 10.1007/s10549-010-0773-7
23. Ma X, Qi X, Chen C, Lin H, Xiong H, Li Y, Jiang J (2010) Association between CYP19 polymorphisms and breast cancer risk: results from 10592 cases and 11720 controls. Breast Cancer Res Treat. doi: 10.1007/s10549-009-0693-6
24. Ma X, Chen C, Xiong H, Fan J, Li Y, Lin H, Xu R, Huang G, Xu B (2010) No association between SOD2 Val16Ala polymorphism and breast cancer susceptibility: a meta-analysis based on 9,710 cases and 11,041 controls. Breast Cancer Res Treat. doi: 10.1007/s10549-009-0725-2
25. N Mantel W Haenszel 1959 Statistical aspects of the analysis of data from retrospective studies of disease J Natl Cancer Inst 22 719 748 1:STN:280:DyaG1M%2FosVOhtQ%3D%3D 13655060
26. R DerSimonian R Kacker 2007 Random-effects model for meta-analysis of clinical trials: an update Contemp Clin Trials 28 105 114 10.1016/j.cct.2006.04. 004 16807131 (Pubitemid 44937874)
27. R DerSimonian N Laird 1986 Meta-analysis in clinical trials Control Clin Trials 7 177 188 10.1016/0197-2456(86)90046-2 1:STN:280:DyaL2s7gsVamtA%3D%3D 3802833 (Pubitemid 17189972)
28. E Ziv J Cauley PA Morin R Saiz WS Browner 2001 Association between the T29 → C polymorphism in the transforming growth factor beta1 gene and breast cancer among elderly white women: the study of osteoporotic fractures JAMA 285 2859 2863 10.1001/jama.285.22.2859 1:CAS:528:DC%2BD3MXkvVOntrY%3D 11401606
29. AJ Sigurdson M Hauptmann N Chatterjee BH Alexander MM Doody JL Rutter JP Struewing 2004 Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes BMC Cancer 4 9 10.1186/1471-2407-4-9 10.1186/1471-2407-4-9 15113441 (Pubitemid 38851364)
30. DL Skerrett EM Moore DS Bernstein 2005 Cytokine genotype polymorphisms in breast carcinoma: associations of TGF-β 1 with relapse Cancer Investig 23 208 214 10.1081/CNV-200055954 1:CAS:528:DC%2BD2MXkslyhu70%3D (Pubitemid 40770738)
31. TR Rebbeck AC Antoniou TC Llopis H Nevanlinna K Aittomäki J Simard AB Spurdle KConFab FJ Couch LH Pereira, et al. 2009 No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study Breast Cancer Res Treat 115 185 192 10.1007/s10549-008-0064-8 1:CAS:528:DC%2BD1MXkvVyru7g%3D 18523885
32. PD Pharoah J Tyrer AM Dunning DF Easton BA Ponder SEARCH Investigators 2007 Association between common variation in 120 candidate genes and breast cancer risk PLoS Genet 3 e42 10.1371/journal.pgen.0030042 10.1371/journal.pgen. 0030042 17367212 (Pubitemid 46535758)
33. A Hishida H Iwata N Hamajima K Matsuo M Mizutani T Iwase S Miura N Emi K Hirose K Tajima 2003 Transforming growth factor B1 T29C polymorphism and breast cancer risk in Japanese women Breast Cancer 10 63 69 10.1007/BF02967627 12525765
34. P Krippl U Langsenlehner W Renner B Yazdani-Biuki G Wolf TC Wascher B Paulweber B Bahadori H Samonigg 2003 The L10P polymorphism of the transforming growth factor-beta 1 gene is not associated with breast cancer risk Cancer Lett 201 181 184 10.1016/S0304-3835(03)00468-3 1:CAS:528:DC%2BD3sXos1Kmt7k%3D 14607332 (Pubitemid 37357167)
35. Q Jin K Hemminki E Grzybowska R Klaes M Soderberg H Zientek J Rogozinska-Szczepka B Utracka-Hutka J Pamula W Pekala A Forsti 2004 Polymorphisms and haplotype structures in genes for transforming growth factor beta1 and its receptors in familial and unselected breast cancers Int J Cancer 112 94 99 10.1002/ijc.20370 1:CAS:528:DC%2BD2cXnvVWlsbk%3D 15305380 (Pubitemid 39249496)
36. L Le Marchand CA Haiman D van den Berg LR Wilkens LN Kolonel BE Henderson 2004 T29C polymorphism in the transforming growth factorβ 1 gene and postmenopausal breast cancer risk: the Multiethnic Cohort Study Cancer Epidemiol Biomarkers Prev 13 412 415 1:CAS:528:DC%2BD2cXhvVygt7o%3D 15006917
37. A Saha V Gupta NK Bairwa D Malhotra R Bamezai 2004 Transforming growth factor-β 1 genotype in sporadic breast cancer patients from India: status of enhancer, promoter, 5-untranslated-region and exon-1 polymorphisms Eur J Immunogenet 31 37 42 10.1111/j.1365-2370.2004.00442.x 1:CAS:528: DC%2BD2cXjtlGjtLw%3D 15009180 (Pubitemid 38387170)
38. VG Kaklamani L Baddi J Liu D Rosman S Phukan C Bradley C Hegarty B McDaniel A Rademaker C Oddoux H Ostrer LS Michel H Huang Y Chen H Ahsan K Offit B Pasche 2005 Combined genetic assessment of transforming growth factor-β signaling pathway variants may predict breast cancer risk Cancer Res 65 3454 3461 1:CAS:528:DC%2BD2MXjt1yrtrg%3D 15833881
39. KM Lee SK Park N Hamajima K Tajima KY Yoo A Shin DY Noh SH Ahn A Hir-vonen D Kang 2005 Genetic polymorphisms of TGF-β1 & TNF-β and breast cancer risk Breast Cancer Res Treat 90 149 155 10.1007/s10549-004-3859-2 1:CAS:528:DC%2BD2MXivVKhs70%3D 15803361 (Pubitemid 40568898)
40. A Shin XO Shu Q Cai YT Gao W Zheng 2005 Genetic polymorphisms of the transforming growth factor-β1 gene and breast cancer risk: a possible dual role at different cancer stages Cancer Epidemiol Biomarkers Prev 14 1567 1570 10.1158/1055-9965.EPI-05-0078 1:CAS:528:DC%2BD2MXkvVCkurg%3D 15941974 (Pubitemid 40807364)
41. HS Feigelson AV Patel WR Diver VL Stevens MJ Thun EE Calle 2006 Transforming growth factorβ receptor type I and transforming growth factorβ 1 polymorphisms are not associated with postmenopausal breast cancer Cancer Epidemiol Biomarkers Prev 15 1236 1237 10.1158/1055-9965.EPI-06- 0163 1:CAS:528:DC%2BD28Xls1ehtrw%3D 16775189
42. L Scola M Vaglica A Crivello L Palmeri GI Forte MC Macaluso A Giacalone L Di Noto A Bongiovanni C Raimondi A Accardo R Verna G Candore C Caruso D Lio S Palmeri 2006 Cytokine gene polymorphisms and breast cancer susceptibility Ann N Y Acad Sci 1089 104 109 10.1196/annals.1386.017 1:CAS:528:DC%2BD2sXhsFertL8%3D 17261759 (Pubitemid 47092072)
43. D Cox K Penney Q Guo S Hankinson D Hunter 2007 TGFB1 and TGFBR1 polymorphisms and breast cancer risk in the nurses' health study BMC Cancer 7 175 10.1186/1471-2407-7-175 10.1186/1471-2407-7-175 17848193 (Pubitemid 350162829)
44. A Jakubowska K Jaworska C Cybulski A Janicka J Szymańska-Pasternak M Lener SA Narod J Lubiński IHCC-Breast Cancer Study Group 2009 Do BRCA1 modifiers also affect the risk of breast cancer in non-carriers? Eur J Cancer 45 837 842 10.1016/j.ejca.2008.10.021 1:CAS:528:DC%2BD1MXisl2rsLY%3D 19071013
45. The MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk (2009) Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women. Breast Cancer Res Treat. doi: 10.1007/s10549-009-0489-8
46. DM Parkin F Bray J Ferlay P Pisani 2005 Global cancer statistics, 2002 CA Cancer J Clin 55 74 108 10.3322/canjclin.55.2.74 15761078
47. P Lichtenstein NV Holm PK Verkasalo 2000 Environmental and heritable factors in the causation of cancer N Engl J Med 343 78 85 10.1056/ NEJM200007133430201 1:STN:280:DC%2BD3czjtFCiug%3D%3D 10891514 (Pubitemid 30451850)
48. TN Sergentanis KP Economopoulos 2010 Association of two CASP8 polymorphisms with breast cancer risk: a meta-analysis Breast Cancer Res Treat 120 229 234 10.1007/s10549-009-0471-5 1:CAS:528:DC%2BC3cXntlakug%3D%3D 19629679
49. Economopoulos KP, Sergentanis TN (2010) Three polymorphisms in cytochrome P450 1B1 (CYP1B1) gene and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. doi: 10.1007/s10549-009-0694-5
50. Qiu LX, Yao L, Yuan H, Mao C, Chen B, Zhan P, Xue K, Zhang J, Hu XC (2010) IGFBP3 A-202C polymorphism and breast cancer susceptibility: a meta-analysis involving 33,557 cases and 45,254 controls. Breast Cancer Res Treat. doi: 10.1007/s10549-010-0739-9
51. Breast Cancer Association Consortium 2006 Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium J Natl Cancer Inst 98 1382 1396
52. AC Janssens AM González-Zuloeta Ladd S López-Léon JP Ioannidis BA Oostra MJ Khoury CM van Duijn 2009 An empirical comparison of meta-analyses of published gene-disease associations versus consortium analyses Genet Med 11 153 162 10.1097/GIM.0b013e3181929237 19367188